A Preliminary and Comparative Evaluation of a Novel Ad5 [E1-, E2b-] Recombinant-Based Vaccine Used to Induce Cell Mediated Immune Responses

Immunology Letters - Netherlands
doi 10.1016/j.imlet.2008.11.003

Related search